When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RYTM - Rhythm Pharma up 38% premarket on positive late-stage setmelanotide data
Rhythm Pharmaceuticals Inc.
Thinly traded Rhythm Pharmaceuticals (NASDAQ:RYTM) is up 38% premarket on increased volume following its announcement of positive results from two Phase 3 clinical trials evaluating setmelanotide for the treatment of pro-opiomelanocortin (POMC) and leptin receptor (LEPR) deficiency obesities.
More news on: Rhythm Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,